1. Role of Sorafenib in Overcoming Resistance of Chemotherapy-Failure Castration-Resistant Prostate Cancer
   Andrew Meyer et al, 2014, Clinical Genitourinary Cancer CrossRef
2. Comparative Aspects of BRAF Mutations in Canine Cancers
   Hiroyuki Mochizuki et al, 2015, Veterinary Sciences CrossRef
3. Adverse Event Management in Patients with BRAF V600E-Mutant Non-Small Cell Lung Cancer Treated with Dabrafenib plus Trametinib
   Anna Chalmers et al, 2019, The Oncologist CrossRef
4. The molecular basis for ethnic variation and histological subtype differences in prostate cancer
   Yang Zong et al, 2013, Science China Life Sciences CrossRef
5. BRAF Mutations in Canine Cancers
   Hiroyuki Mochizuki et al, 2015, PLOS ONE CrossRef
6. BRAF gene: From human cancers to developmental syndromes
   Muhammad Ramzan Manwar Hussain et al, 2015, Saudi Journal of Biological Sciences CrossRef
7. KRAS, BRAF, PIK3CA mutation frequency of radical prostatectomy samples and review of the literature
   Atike Bahcivan et al, 2020, The Aging Male CrossRef
8. CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo
   Abdullah Alajati et al, 2020, Journal of Clinical Investigation CrossRef
9. Estrogen receptor alpha drives proliferation in PTEN-deficient prostate carcinoma by stimulating survival signaling, MYC expression and altering glucose sensitivity
   Itsuhiro Takizawa et al, 2015, Oncotarget CrossRef
10. Targeting BRAF-Mutant Non-Small Cell Lung Cancer: From Molecular Profiling to Rationally Designed Therapy
    Christina S. Baik et al, 2017, The Oncologist CrossRef
11. Tumors of the Male Reproductive System
    Jessica A. Lawrence et al, 2019, Withrow and MacEwen's Small Animal Clinical Oncology CrossRef
12. The Epidemiology and Clinical Implications of Genetic Variation in Prostate Cancer
    Brian T. Helfand et al, 2014, Urologic Clinics of North America CrossRef